TMB-H + EGFR mutation	Non Small Cell Lung Cancer	TMB-H + EGFR mutation	Non Small Cell Lung Cancer	PD-L1 inhibitor Sensitive: C3 – Early Trials PD-L1 inhibitor Sensitive : C3	PD-L1 inhibitor Sensitive: C3 – Early Trials PD-L1 inhibitor Sensitive : C3
TMB-H + EGFR mutation	Lung Adenocarcinoma	TMB-H + EGFR mutation	Lung Adenocarcinoma	EGFR inhibitor Resistant: C3 – Early Trials EGFR inhibitor Resistant : C3	EGFR inhibitor Resistant: C3 – Early Trials EGFR inhibitor Resistant : C3

TMB-H + EGFR mutation

Associations